Proposed placing of unlisted warrants under Specific mandate
Filed with HKEX · Stock code 3378 · · 17 pages · English
This announcement is for information purpose only and does not constitute an invitation or offer to acquire, purchase or subscribe for any securities of the Company. Hanx Biopharmaceuticals (Wuhan) Co., Ltd. 翰思艾泰生物醫藥科技（武漢）股份有限公司 (A joint stock company incorporated in the People’s Republic of China with limited liability) (Stock Code: 3378) PROPOSED PLACING OF UNLISTED WARRANTS UNDER SPECIFIC MANDA
Hanx Biopharmaceuticals (Wuhan) Co. Ltd. on 6ix
Earlier from Hanx Biopharmaceuticals (Wuhan)
- Next Day Disclosure Return
- Voluntary announcement notice on voluntary extension of lock-up period by shareholders
- Voluntary announcement inclusion of Hanx Biopharmaceuticals in the FTSE global micro cap index
Later from Hanx Biopharmaceuticals (Wuhan)
- 2026 Interim report
- Voluntary announcement entering into strategic cooperation with xtalpi
- Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 30 September 2026
Follow Hanx Biopharmaceuticals (Wuhan) into a list and get an email when it puts out news.
Follow Hanx Biopharmaceuticals (Wuhan)